145 related articles for article (PubMed ID: 30718865)
1. The shrinking biotech bazaar.
Nat Biotechnol; 2019 Feb; 37(2):107. PubMed ID: 30718865
[No Abstract] [Full Text] [Related]
2. Building for an exit (or not).
Gunning TG
Nat Biotechnol; 2008 Sep; 26(9):971-3. PubMed ID: 18792427
[TBL] [Abstract][Full Text] [Related]
3. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
4. Biotech firms jump on SARS bandwagon.
Basu P
Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
[No Abstract] [Full Text] [Related]
5. Biotech at the beauty counter.
Nasto B
Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
[No Abstract] [Full Text] [Related]
6. Biotech meets the investors.
Berry S
Trends Biotechnol; 2002 Sep; 20(9):370-1. PubMed ID: 12175762
[No Abstract] [Full Text] [Related]
7. Merck wipes Serono off Swiss biotech map.
Urquhart L
Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
[No Abstract] [Full Text] [Related]
8. The number on biotech indexes.
Jacobs T
Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
[No Abstract] [Full Text] [Related]
9. Editorial: Biotech in the financial crisis.
Jungbauer A
Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
[No Abstract] [Full Text] [Related]
10. Biotech R&D still reeling.
Lawrence S
Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
[No Abstract] [Full Text] [Related]
11. Patent threat in emerging economies shifts to biotech.
Jayaranam K
Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
[No Abstract] [Full Text] [Related]
12. Pharmas partner in venture seeking drug discovery tools.
Mack GS
Nat Biotechnol; 2008 Sep; 26(9):960-1. PubMed ID: 18779790
[No Abstract] [Full Text] [Related]
13. rFactor VIII deficit questioned.
Garber K
Nat Biotechnol; 2000 Nov; 18(11):1133. PubMed ID: 11062420
[No Abstract] [Full Text] [Related]
14. Aurora throws light on Vertex's aspirations.
Fletcher L
Nat Biotechnol; 2001 Jun; 19(6):496. PubMed ID: 11385416
[No Abstract] [Full Text] [Related]
15. The business of making vaccines.
Sheridan C
Nat Biotechnol; 2005 Nov; 23(11):1359-66. PubMed ID: 16273061
[TBL] [Abstract][Full Text] [Related]
16. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
17. Biotech slumps in Q1.
Lawrence S
Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
[No Abstract] [Full Text] [Related]
18. The further evolution of biotech.
Nagle T; Berg C; Nassr R; Pang K
Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
[TBL] [Abstract][Full Text] [Related]
19. Today's biotech industry in India.
Suresh N
Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
[No Abstract] [Full Text] [Related]
20. Calculating the value & risk in licensing deals. 20-21 November 2002, Brussels, Belgium.
Contrafouris Y
IDrugs; 2003 Jan; 6(1):21-2. PubMed ID: 12838965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
